<DOC>
	<DOCNO>NCT01518244</DOCNO>
	<brief_summary>The purpose study assess efficacy tolerability change AZARGA速 prior COMBIGAN速 pharmacotherapy participant open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Assessing Efficacy Tolerability AZARGA速 ( Brinzolamide 1 % /Timolol 0.5 % Fixed Combination ) Replacement Therapy Patients Brimonidine 0.2 % /Timolol 0.5 % Fixed Combination Therapy ( COMBIGAN速 ) Latin America</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Brimonidine Tartrate , Timolol Maleate Drug Combination</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<criteria>Clinical diagnosis ocular hypertension , exfoliative openangle glaucoma , pigment dispersion glaucoma least one eye ( study eye ) . On stable IOP ( intraocular pressure ) lower regimen within 30 day Screening Visit . IOP consider safe eye order assure clinical stability vision optic nerve throughout study period . Best correct visual acuity 6/60 ( 20/200 Snellen ; 1.0 LogMAR ) good eye . IOP 19 35 mmHG least one eye ( would study eye ) brimonidine/timolol fix combination therapy . Other protocoldefined inclusion criterion may apply . Presence primary secondary glaucoma . History ocular herpes simplex . Any abnormality prevent reliable applanation tonometry . Corneal dystrophy . Concurrent infectious/noninfectious conjunctivitis , keratitis , uveitis either eye . Blepharitis nonclinically significant conjunctival injection allow . Intraocular conventional surgery laser surgery study eye ( ) less three month prior Screening Visit . Risk visual field visual acuity worsen consequence participation study , opinion investigator . Progressive retinal optic nerve disease cause . Use systemic medication know affect IOP stable course 7 day prior Screening Visit anticipated change dosage course study . Pregnant lactating . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Primary open angle-glaucoma</keyword>
	<keyword>Ocular hypertension</keyword>
	<keyword>Pigment dispersion glaucoma</keyword>
</DOC>